Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virus-Cell Interactions

Interaction of Calpactin Light Chain (S100A10/p11) and a Viral NS Protein Is Essential for Intracellular Trafficking of Nonenveloped Bluetongue Virus

Cristina C. P. Celma, Polly Roy
Cristina C. P. Celma
Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Polly Roy
Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: polly.roy@lshtm.ac.uk
DOI: 10.1128/JVI.02352-10
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Schematic representation of NS3. The two cytoplasmic domains (N terminal and C terminal), the two transmembrane domains (TM), and the extracellular domain (EC) are indicated. Numbers above indicate amino acid position according to the NS3 amino acid sequence. The glycosylation site at asparagine position 150 is also shown (arrow). The changes in either the first or the second methionine residue introduced by site-directed mutagenesis are shown in the lower panel; dots indicate no change, and dashes indicate absence of expressed residues.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Characterization of BTVM1 and BTVM14 mutant viruses. (A) The total titer at different time points postinfection for either mutant or WT viruses in complementary BSR/NS3 cells (left panel) or normal BSR cells (right panel) was determined, expressed as PFU/ml, and plotted on a logarithmic scale. (B) The expression of NS3 was assessed in cell lysates from mammalian BSR cells at 48 h postinfection with mutant virus BTVM1 (lane 2) or BTVM14 (lane 3); cell lysates from mock-infected cells (lane 4) or WT-infected cells (lane 1) were included. Lane M, molecular mass standard in kDa. Western blotting was performed using an antibody against BTV NS3. (C) Genomic dsRNA from BSR cells infected with WT virus (lane 1) or mutant virus BTVM1 (lane 2) or BTVM14 (lane 3) was purified and analyzed on a nondenaturing polyacrylamide gel.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Interaction of BTV NS3 with S100A10/p11 in infected mammalian cells. (A) Colocalization of NS3 (green) with S100A10/p11 (red). BSR cells were infected with WT or mutant viruses as indicated and at 24 h postinfection were fixed, permeabilized, and processed for confocal microscopy. (B) Coimmunoprecipitation of NS3 and S100A10/p11. BSR cells were infected with WT virus (lane 1) or mutant viruses BTVM1 (lane 2) and BTV M14 (lane 3) and at 36 h postinfection were harvested and processed as described in Materials and Methods. Expression of NS3 in cell lysates was assayed by Western blotting using an antibody against NS3 (left panel). As control, a lysate from noninfected cells (lane 4) was included. The coimmunoprecipitation of NS3 WT virus (right panel, lane 1) or mutants M1 (lane 2) and M14 (lane 3) with S100A10/p11 was performed using a monoclonal antibody that recognized S100A10/p11 and analyzed by Western blotting with an antibody against NS3. As controls, a lysate from mock-infected cells (lane 4) and a lysate from cells infected with WT virus but without antibody against S100A10/p11 (lane 5) were included.

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Schematic representation of the substitution mutations introduced in the N-terminal end of NS3. Specific changes in the first 13 residues in each mutant (Q7P, R8E, and E10A) are indicated. Dots indicate no change.

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    Characterization of mutant BTVQ7P, BTVR8E, and BTVE10A viruses. (A) Complementary BSR/NS3 cells (left panel) or normal BSR cells (right panel) were infected with mutant virus BTV Q7P, R8E, or E10A or with the WT and harvested at different time points postinfection as indicated. Total titer was determined by plaque assay, expressed as PFU/ml, and plotted on a logarithmic scale. (B) The expression of NS3 was assessed by Western blotting in BSR cell lysates processed at 48 h postinfection with mutant virus Q7P (lane 1), R8E (lane 2), or E10A (lane 3). Lysate from cells infected with WT BTV (lane 4) was included as control. The number on the left indicate the molecular mass standard in kDa. (C) Genomic dsRNA purified from BSR cells infected with BTVQ7P (lane 2), BTVR8E (lane 3), or BTVE10A (lane 4) was purified and analyzed in a nondenaturing polyacrylamide gel. As a control, dsRNA from WT virus was included (lane 1).

  • Fig. 6.
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Effects of single substitutions in NS3 on NS3-S100A10/p11 interaction. (A) Colocalization of NS3/NS3A (green) with S100A10/p11 (red) proteins. BSR cells were infected with mutant viruses as indicated and at 24 h postinfection were processed for confocal microscopy as described in Materials and Methods. (B) Interaction of NS3 with S100A10/p11. BSR cells were infected with WT or mutant viruses and at 36 h postinfection cells were processed as described in Materials and Methods. The expression of NS3 in lysate from cells infected with BTVQ7P (lane 1), BTVR8E (lane 2), or BTVE10A (lane 3) was verified by Western blotting (left panel). The coimmunoprecipitation of NS3 using a monoclonal antibody that recognizes S100A10/p11 was analyzed by Western blotting using the antibody against NS3 (right panel).

  • Fig. 7.
    • Open in new tab
    • Download powerpoint
    Fig. 7.

    Ultrastructural analysis of mammalian cells infected with mutant or WT viruses. BSR cells were infected with WT, BTVM1, BTVM14, or BTVQ7P virus, and at 24 h postinfection cells were processed for sectioning. Arrows in the left panels indicate particles. An area of each section is amplified in the right panels to show the detail. Bars, 500 nm.

  • Fig. 8.
    • Open in new tab
    • Download powerpoint
    Fig. 8.

    Virus growth and virus release from Culicoides-derived cells. (A) KC cells were infected with mutant BTVM1, BTVM14, BTVQ7P, BTVR8E, or BTVE10A or with WT virus, and at 1, 2, and 3 days postinfection cells and supernatant were harvested and the total titer was determined by plaque assay. (B) KC cells were infected with mutant or WT viruses, and at 4 days postinfection cell-free and cell-associated fractions were collected. The titer of each fraction was determined and the relative release calculated as the ratio of cell-free to total virus titer, normalized for the control virus, and plotted on a logarithmic scale. Bars represent the averages and standard deviations from at least two experiments.

  • Fig. 9.
    • Open in new tab
    • Download powerpoint
    Fig. 9.

    Cell sectioning analysis of infected insect Culicoides cells. (A) KC cells were infected with WT virus, harvested at 2, 4, and 6 days postinfection, and processed for cell sectioning. White arrows indicate virus particles and black arrows membrane structures. (B) KC cells were infected with mutant BTVM1, BTVM14, or BTVQ7P viruses as indicated and processed at 6 days postinfection. Bar, 500 nm.

PreviousNext
Back to top
Download PDF
Citation Tools
Interaction of Calpactin Light Chain (S100A10/p11) and a Viral NS Protein Is Essential for Intracellular Trafficking of Nonenveloped Bluetongue Virus
Cristina C. P. Celma, Polly Roy
Journal of Virology Apr 2011, 85 (10) 4783-4791; DOI: 10.1128/JVI.02352-10

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Interaction of Calpactin Light Chain (S100A10/p11) and a Viral NS Protein Is Essential for Intracellular Trafficking of Nonenveloped Bluetongue Virus
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Interaction of Calpactin Light Chain (S100A10/p11) and a Viral NS Protein Is Essential for Intracellular Trafficking of Nonenveloped Bluetongue Virus
Cristina C. P. Celma, Polly Roy
Journal of Virology Apr 2011, 85 (10) 4783-4791; DOI: 10.1128/JVI.02352-10
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514